Centro de Estudios Reumatologicos

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva	Ossification, Heterotopic, Pathologic Processes, Pathological Conditions, Signs and Symptoms, muscle tissue disorder, musculoskeletal system disorder, myositis disease, myositis ossificans	Recruiting	Phase 2	2026-05-22		NCT05090891
A Study of the Efficacy and Safety of Efgartigimod in Patients With Primary Sjögren's Syndrome	Primary Sjogrens Disease	Active, not recruiting	Phase 3	2026-04-16		NCT06684847

Clinical trials